Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression.

Seventeen families with Emery-Dreifuss muscular dystrophy (EDMD) have been studied both by DNA sequencing and by emerin protein expression. Fourteen had mutations in the X-linked emerin gene, while three showed evidence of autosomal inheritance. Twelve of the 14 emerin mutations caused early termination of translation. An in-frame deletion of six amino acids from the C-terminal transmembrane helix caused almost complete absence of emerin from muscle with no localization to the nuclear membrane, although mRNA levels were normal. This shows that mutant emerin proteins are unstable if they are unable to integrate into a membrane. A 22 bp deletion in the promoter region was expected to result in reduced emerin production, but normal amounts of emerin of normal size were found in leucocytes and lymphoblastoid cell lines. This shows that DNA analysis is necessary to exclude emerin mutations in suspected X-linked EDMD. Emerin levels in female carriers often deviated from the expected 50% and this was due, in at least two families, to skewed emerin mRNA expression from the normal and mutated alleles. In one family with a novel deletion of the last three exons of the emerin gene, a carrier had a cardiomyopathy and very low emerin levels (<5% of normal) due to skewed X-inactivation. In the three autosomal cases of EDMD, emerin was normal on western blots of blood cells, which suggests that autosomal EDMD is not caused by indirect reduction of emerin levels.

[1]  J. Yates,et al.  The Emery-Dreifuss Muscular Dystrophy Mutation Database. , 1999, Neuromuscular disorders : NMD.

[2]  F. Muntoni,et al.  Early presentation of X-linked Emery–Dreifuss muscular dystrophy resembling limb-girdle muscular dystrophy , 1998, Neuromuscular Disorders.

[3]  L. Cartegni,et al.  Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy. , 1997, Human molecular genetics.

[4]  S. Bione,et al.  X‐linked emery‐dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample , 1997, Annals of neurology.

[5]  F. Muntoni,et al.  Diagnosis of X-linked Emery-Dreifuss muscular dystrophy by protein analysis of leucocytes and skin with monoclonal antibodies , 1997, Neuromuscular Disorders.

[6]  J. Parrish,et al.  Six novel mutations in the emerin gene causing X‐linked Emery‐Dreifuss muscular dystrophy , 1997 .

[7]  S. Manilal,et al.  The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. , 1996, Human molecular genetics.

[8]  J. Chelly,et al.  Mutations and phenotype in isolated glycerol kinase deficiency. , 1996, American journal of human genetics.

[9]  永野 敦 Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy , 1996 .

[10]  A. Ciccodicola,et al.  SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function. , 1995, Human molecular genetics.

[11]  A. Ciccodicola,et al.  Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the disease. , 1995, Human molecular genetics.

[12]  J. Siekierka,et al.  Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2. , 1995, Genomics.

[13]  U. Aebi,et al.  Cloning of a cDNA for lamina‐associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. , 1995, The EMBO journal.

[14]  J. Vallat,et al.  [Total permanent auricular paralysis. Review of the literature apropos of 109 cases]. , 1995, Annales de cardiologie et d'angeiologie.

[15]  E. Maestrini,et al.  Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy , 1994, Nature Genetics.

[16]  B. Katirji Diagnostic Criteria for Neuromuscular Disorders , 1994, Neurology.

[17]  K. Davies,et al.  Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7. , 1993, American journal of human genetics.

[18]  H. Worman,et al.  The amino-terminal domain of the lamin B receptor is a nuclear envelope targeting signal , 1993, The Journal of cell biology.

[19]  K. Davies,et al.  Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines , 1991, The Journal of cell biology.

[20]  A. Emery Emery-Dreifuss syndrome. , 1989, Journal of medical genetics.

[21]  K. Fischbeck,et al.  Duchenne muscular dystrophy gene expression in normal and diseased human muscle. , 1988, Science.

[22]  R. Gibbs,et al.  Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. , 1988, Science.

[23]  M. Lyon Sex chromatin and gene action in the mammalian X-chromosome. , 1962, American journal of human genetics.